IPO Is Major Strategy For American Med Labs

CEO SUMMARY: Since its acquisition in 1997, American Medical Laboratories’ fast growth was funded by heavy borrowing. Now this Virginia-based lab company needs to raise additional capital so it can restructure its debt and lay a foundation for the next cycle of growth. Its initial public offering of common stock will need to compete with …

IPO Is Major Strategy For American Med Labs Read More »

To access this post, you must purchase The Dark Report.

IPO Is Major Strategy For American Med Labs

AML wants to raise $115 million from its initial public offering

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month